TIFFANY WHIGHAM: Open Payments
NPI 1588920862 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 30 payments from 12 companies in 2025. Trend: 2023 $1,104 · 2024 $832 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $149 |
| Boston Scientific Corporation | 6 | $115 |
| Imperative Care, Inc | 4 | $95 |
| Amgen Inc. | 4 | $64 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
| Novo Nordisk Inc | 2 | $54 |
| Inspire Medical Systems, Inc. | 2 | $38 |
| PFIZER INC. | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: AVEIR, SYMPHONY CATHETER, BodyGuardian, REPATHA, FARXIGA, INSPIRE, VYNDAQEL, CARDIOMEMS.
Industry payments across TX — which companies pay providers there.
